WO2002056017A1 - Lateral flow assay for detection of antibodies in human serum - Google Patents
Lateral flow assay for detection of antibodies in human serum Download PDFInfo
- Publication number
- WO2002056017A1 WO2002056017A1 PCT/US2001/042668 US0142668W WO02056017A1 WO 2002056017 A1 WO2002056017 A1 WO 2002056017A1 US 0142668 W US0142668 W US 0142668W WO 02056017 A1 WO02056017 A1 WO 02056017A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- lateral flow
- site
- flow immunoassay
- immunoassay device
- antibodies
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/97—Test strip or test slide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/807—Apparatus included in process claim, e.g. physical support structures
- Y10S436/81—Tube, bottle, or dipstick
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/821—Chemistry: analytical and immunological testing involving complement factors or complement systems
Definitions
- the present invention discloses a method and composition for detecting the presence of antibodies in human or animal bodily fluids (blood, serum, plasma, urine, colostrum, milk, tears, or saliva) to analytes such as bacteria, Chlainydiae, Rickettsiae, protozoa, allergens, autoimmune antigens, viral proteins, and carbohydrates by lateral flow techniques.
- analytes such as bacteria, Chlainydiae, Rickettsiae, protozoa, allergens, autoimmune antigens, viral proteins, and carbohydrates by lateral flow techniques.
- a plastic or paper housing allowing the viewing of a reaction area on a bibulous (lateral flow) strip; b) An opening at one end of the housing allowing for the addition of sample (urine, blood, plasma, serum or bacteria in a media base); c) Bibulous material (the lateral flow strip) having immobilized specific binding members (analytes) capable of reacting with antigens or antibodies.
- a pad of absorbent bibulous material (the absorbent pad) enclosed at the end opposite the sample well and used to absorb transversely flowing sample, buffers and colloids; e) A strip of bibulous material used in the sample well end to initially absorb the sample being applied; f) A strip of bibulous material in contact with the sample well material and the lateral flow strip and containing a dried colored solid phase reagent, the solid phase coated with proteins or haptens.
- proteins or small molecule analytes contained in human fluids are detected.
- the analytes include hCG, FSH, LH, CKMB, TSH, troponins, myoglobulin, cancer proteins, viral/bacterial proteins, haptens, therapeutic drugs, and drugs of abuse.
- the analyte being detected is human antibody specifically reactive with agents such as viral/bacterial proteins (HIV, Hepatitis A and C, H. pylori, EBN, Rubella, CMN, HSN, Dengue fever, Lyme, Chagas, TB, Toxoplasma, autoimmune antigens, etc.) or allergens (pollens, molds, dust/mites, foods, animal epithelia, etc.).
- agents such as viral/bacterial proteins (HIV, Hepatitis A and C, H. pylori, EBN, Rubella, CMN, HSN, Dengue fever, Lyme, Chagas, TB, Toxoplasma, autoimmune antigens, etc.) or allergens (pollens, molds, dust/mites, foods, animal epithelia, etc.).
- agents such as viral/bacterial proteins (HIV, Hepatitis A and C, H. pylori, EBN, Rubella, CMN, HSN, Dengue fever,
- the colored solid phase [SP] is coated with proteins or lectins [ protein A, protein G, lentil lectin, jacalin, concanavilin A, mannan binding protein, wheat germ lectin, peanut lectin and avidchrom] that react with human IgG antibodies.
- the solid phase may be coated with anti-immunoglobulins that specifically react with IgG, IgM, IgA, or IgE.
- the bibulous strip would in this case contain the analyte (NB) of interest to which the specific antibody contained in the sample reacts.
- the colored solid phase contains the analyte (NB) to which the human immunoglobulins react.
- the bibulous strip would in this case also contain the analyte (NB) of interest to which the specific antibody contained in the sample reacts.
- the colored solid phase contains the analyte (NB) to which immunoglobulins react.
- the bibulous strip contains proteins directed against human IgG or total immunoglobulins (protein A, ,protein G, lectins, lentil lectin, jacalin, concanavilin A, mannan binding protein, wheat germ lectin, peanut lectin and avidchrom or a mix of antibody to immunoglobulin classes IgG, IgA ,IgM and IgE).
- proteins directed against human IgG or total immunoglobulins protein A, ,protein G, lectins, lentil lectin, jacalin, concanavilin A, mannan binding protein, wheat germ lectin, peanut lectin and avidchrom or a mix of antibody to immunoglobulin classes IgG, IgA ,IgM and IgE).
- 5,459,041 discloses antigenic compositions for use in diagnostic kits and the like for detecting the presence of antibodies specific for Campylobacter pylori.
- Samples of bodily fluids may be contacted with immobilized antigen on a solid phase which is then washed and tested for the occurrence of significant levels of antigen/antibody complex.
- Levels exceeding a predetermined positive threshold are indicative of antibodies to Campylobacter pylori in the sample tested.
- Kits employing the antigenic compositions of the invention preferably include means for detecting the antigen/antibody complex such as materials and reagents for conducting an enzyme-linked immunosorbent assay, Western blot technique, ELISA, liposome-based assay or other known detection tests.
- the Western blot and ELISA tests used here are for the detection of IgA and IgG antibodies.
- U.S. Patent No. 5,567,594 discloses a library of isolated and purified antigens specific for a microorganism is a set of individual molecules.
- the library forms antigen-antibody complexes useful in the context of diagnosing and treating conditions associated with a specific microorganism such as H. pylori-induced gastro-duodenal disease.
- the antibody in question is an immunoglobulin, which is IgE if the antigens are allergens.
- Antigen-antibody complexes with IgA, IgG and IgM are also useful if the antigen is a bacteria..
- a specific condition is diagnosed with high sensitivity and specificity by determining whether complexes form between a specific antigen library and a biological sample which contains immunoglobulins from an individual.
- libraries also are useful for immunotherapy.
- Western blot is used to detect IgE antibodies. The method requires enzyme conjugates and enzyme substrates and two wash steps to detect antibodies.
- U.S. Patent No. 5,420,014 discloses a method for detecting a current infection by H. pylori in a mammal.
- the method comprises contacting a mucous secretion [saliva] from said mammal with an immobilized antigen component from H. pylori for a time and under conditions sufficient for an IgG antibody in said mucous secretion specific to a antigen component to form a complex therewith and then subjecting said complex to a detecting means which involves an enzyme conjugate and specific substrate.
- U.S. Patent No. 6,068,985 discloses a method which uses saliva to detect IgG in both the Western Blot and ELISA tests. This detection method requires the use of an enzyme conjugate and enzyme substrate and two wash steps to detect the antibody.
- U.S. Patent No. 5,846,751 discloses a sensitive and specific antigen preparation for the detection of Helicobacter pylori in biological samples.
- the preparation uses a range of antigens derived from size exclusion chromatography of detergent-solubilized H. pylori cells and the purified antigen preparation is coated on the solid phase.
- Serological assays such as ELISA, latex agglutination, and rapid EIA assays are used to detect antibodies to H. pylori.
- the invention also uses a lateral flow device to detect total immunoglobulins to H. pylori. In this case, the H.
- Pylori antigen is striped on the membrane reaction area and also coated to the colored solid phase.
- the antibody in the sample reacts first with H. pylori gold coated conjugate, and then travels to the membrane reaction area where it reacts with striped H. pylori.
- U.S. Patent No. 5,200,344 (Blaser et al) uses a purified p28kd protein from H. pylori to detect IgA, IgM and IgG antibody in ELISA and Western Blot. The test requires conjugate and enzyme substrate and two wash steps to detect the antibody.
- U.S. Patent No. 6,060,326 and 5,945,294 discloses methods to detect canine IgE using a canine Fc epsilon receptor to detect canine IgE antibodies in a biological sample from a canine.
- U.S. Patent No. 5,547,833 discloses a radial flow assay delivery device , and methods of use.
- the IgG will mask most if not all the analyte (VB) epitopes, thereby decreasing or eliminating the activity of the IgM, IgA, and IgE class antibodies to the analyte (NB).
- VB analyte
- a lateral flow immunoassay device distinguishes at least three classes of antibody.
- the classes of antibody to be distinguished include IgG, IgA and IgM.
- a control line reactive with gold particles is also present. .
- the immunoassay test strip is modified to allow detection of the IgE class of antibody to many allergens (VB) coated sequentially on a bibulous strip.
- Saturated anti-IgE antibodies coated to colored solid [SP] phase particles at high concentration are reacted with a controlled amount of serum to allow for the near complete complexing of elevated levels of human or other animal IgE. This insures that little free IgE is left unreacted. Unreacted IgE would inhibit the reaction with the multiple analytes coated on the bibulous strip.
- sufficient IgE specific antibody molecules are available to react with the various allergens (VB) as the reaction front moves transversely down the strip toward the absorbent pad. This allows for the detection of many different IgE allergen specific molecules.
- an IgG reacting protein (which can be protein A, protein G, an antibody to IgG or lectins such as lentil lectin, jacalin, concanavilin A, mannan binding protein, wheat germ lectin, peanut lectin and avidchrom) is added to the sample pad in order to complex the IgG contained in the sample such that the molecular weight of the IgG complex is greater than 1.0 million.
- This large complex travels sufficiently slower than IgA, IgM, and IgE thereby allowing these antibodies to react prior to the IgG.
- the various reacted complexes are captured on the bibulous strip coated at three sites with antibody to IgM, IgA and IgG or a protein/lectin reactive with IgG (protein A, protein G, lentil lectin, jacalin, concanavilin A, mannan binding protein, wheat germ lectin, peanut lectin and avidchrom).
- IgM immunoglobulin M
- IgA immunoglobulin G
- lentil lectin protein G
- jacalin concanavilin A
- mannan binding protein wheat germ lectin
- peanut lectin and avidchrom avidchrom
- the colored solid phase contains proteins that react with IgG, allowing for the detection of many different analyte specific antibody molecules of the IgG class.
- the reagents coated onto the bibulous lateral flow strip include autoimmune antigens, allergens, Chlamidia, Rickettsiae, viruses, and bacteria.
- Fig. 1 is a perspective view of one embodiment of the lateral flow immunoassay test
- Fig. 2 is a perspective view of another embodiment of the lateral flow immunoassay test
- Fig. 3 is an exploded view of the lateral flow immunoassay test
- Fig. 4 is a side view of the test strip
- Fig. 5 is a view of the colored particles attached to the antigen.
- Fig. 6 is an exploded view of another version of the lateral flow immunoassay test. DETAILED DESCRIPTION OF THE INVENTION
- the immunoassay lateral flow test system 1 comprises a casing 2, preferably plastic, surrounding a test strip 7. On the top surface of the test strip there is a sample opening 8 and a test results opening 9 to show the results of the assay.
- the casing can take a number of different forms. In Figures 3 and 6, , the casing has a top section 4 or 100, and a bottom section 5 or 101. Within the top section 4 there is at least one channel 6 into which is fitted a test strip 7.
- the test strip 7 preferably has a membrane support 10.
- the membrane support 10 may be comprised of plastic, cardboard, or any other rigid material.
- On top of the membrane support 10 is a testing layer 11, preferably made out of nitrocellulose.
- On top of the nitrocellulose or testing layer 11 are the areas to which the appropriate reagents or samples are applied or affixed.
- the nitrocellulose/testing layer may be affixed to the membrane support 10.
- sample site 12 At one end of the test strip 7 is the sample site 12 to which the sample is to be applied.
- This sample site 12 preferably has a sample pad 13 residing on top of the testing layer, to which the sample is transferred.
- the sample is preferably a bodily fluid. This fluid may be serum whole blood, plasma, colostrum, milk, saliva, tears, or urine sample from a human or other animal species.
- Incorporated in the sample site 12 or sample pad 13, or downstream from the sample site is the labeled antigen, for which the serum is being tested.
- the gold particles 14 attached to the antigen or antibody 15 are preferably larger than 20 urn, more preferably in the range of about 20 to 100 nm, and most preferably in the range of 20 to 40 nm.
- the gold sol labeled antigens/antibodies 35 are dried and deposited on the strip 7.
- the metal sol particles to be used in accordance with the present invention may be prepared by coupling the analyte directly to the gold particle.
- the labeled component may be prepared by coupling the analyte to the particle using a biotin/avidin linkage.
- the substance may be biotinylated and the metal containing particle coated with an avidin compound. The biotin on the analyte may then be reacted with the avidin compound on the particle to couple the substance and the particle together.
- the labeled component may be prepared by coupling the analyte to a carrier such as bovine serum albumin (BSA),key hole lymphocyananin (KLH), or ovalbumin and using this to bind to the metal particles.
- a carrier such as bovine serum albumin (BSA),key hole lymphocyananin (KLH), or ovalbumin
- the metal sol particles to be used in accordance with the present invention may be prepared by methodologies which are well known. For instance, the preparation of gold sol particles is disclosed in an article by G. Frens, Nature, 241, 20-22 (1973). Additionally, the metal sol particles may be metal or metal compounds or polymer nuclei coated with metals or metal compounds, as described in U.S. Pat No. 4,313,734. Other methods well known in the art may be used to attach the analyte to gold particles. The methods include but are not limited to covalent coupling and hydrophobic bonding.
- the metal sol particles may be made of platinum, gold, silver, selenium, or copper or any number of metal compounds which exhibit characteristic colors.
- the analyte does not necessarily have to be attached to a metal sol particle, but may instead be attached to dyed or fluorescent labeled microparticles such as latex, polystyrene, dextran, silica, polycarbonate, methylmethacrylates and carbon.
- dyed or fluorescent labeled microparticles such as latex, polystyrene, dextran, silica, polycarbonate, methylmethacrylates and carbon.
- the metal sol particles , dyed or fluorescent labeled microparticles should be visible to the naked eye or able to be read with an appropriate instrument (spectrophotometer, fluorescent reader, etc. ).
- the gold labeled antigens 16 may be deposited on the strip 7.
- the gold labeled antigens/antibodies are deposited and dried on a rectangular or square absorbent pad 16, the pad preferably about .25" x .25"or less.
- This absorbent pad 16 is positioned downstream from where the sample is applied on the strip 7.
- the analytes may be attached to microspheres. This has the effect of increasing the number of reactive sites (epitopes) in a given area. Analytes may be attached to these alternate solid phases by various methodologies.
- reactive microspheres (MX-Covaspheres R of diameter .5 micrometers or .9 micrometers) purchased from Duke Scientific Corporation, Pal Alto, California 94303, or other suppliers, may be used to covalently attach analytes.
- the binding is at the amino groups of the protein if covalent methodology is used.
- hydrophobic or electrostatic domains in the protein may be used for passive coating.
- a suspension of the spheres is mixed after sonication with the antigens/antibodies in water or in a phosphate buffer solution, after which they are incubated at room temperature for 10-75 minutes.
- the mixture is then centrifuged and the pellets containing the antigen/antibody-linked microspheres are suspended in a buffer containing 1-5% wt/volume bovine serum albumin (BSA) for 1 hour at room temperature.
- BSA bovine serum albumin
- the BSA blocks any unreacted surfaces of the microspheres.
- the spheres are resuspended in buffer (TBS with 5% BSA) and stored at 4 degrees C before using.
- the solid phase particles may comprise any one of known, water dispersable particles, such as, the polystyrene latex particles disclosed in U.S. Patent No. 3,088,875. Such solid phase materials simply consist of suspensions of small, water-insoluble particles to which antigens/antibodies are able to bind. Suitable solid phase particles are also disclosed, for example, in U.S. Patent Nos. 4,184,849; 4,486,530; and 4,636,479.
- the analytes may be attached to fluorescent microspheres or fluorescent microparticles.
- Said fluorescent micropaticles may be purchased from Duke Scientific, Palo Alta, California 94303 and are listed as Green, Red, or Blue fluorescent 0.4 micron microspheres (Product Bulletin 93). They are also available from Molecular Probes, Eugene, Oregon 97402 and are listed as FluoroSpheres; Blue, Yellow-Green, Nile Red, Orange, Red, Crimson, Dark Red and Far Red in micron sizes from 0.03 to 5.0. Other manufactures also supply fluorescent microspheres. Characteristically, fluorescent microspheres incorporate fluorescent dyes in the solid outer matrix or in the internal volume of the microsphere.
- the fluorescent spheres are typically detected by a fluorescent reader that excites molecules at one wavelength and detects the emission of fluorescent waves at another wavelength.
- Molecular Probes Nile Red particles excite at 526 nm at emit at 574 nm, the Far Red excites at 680 nm and emits at 720 nm and the Blue excites at 365 nm and emits at 430 nm.
- detection of fluorescent microparticles requires the use of a reflectance reader with an appropriate excitation source (HeNe, Argon, tungsten or diode laser) and an appropriate emission filter for detection.
- diode lasers allows for use of detection systems that use low cost lasers with detection above 600 nm.
- Fluorescent microspheres contain surface functional groups such as carboxylate, sulfate and aldehyde groups, making them suitable for covalent coupling of proteins and other amine containing biomolecules.
- surface functional groups such as carboxylate, sulfate and aldehyde groups, making them suitable for covalent coupling of proteins and other amine containing biomolecules.
- sulfate, carboxyl and amidine microspheres are hydrophobic particles that will passively absorb almost any protein or lectin. Coating is thus similar as for non fluorescent microspheres ( MX-Covaspheres or other latex microparticles).
- a suspension of the fluorescent spheres is mixed after sonication with the antigens/antibody in water or in a phosphate buffered solution, after which they are incubated at room temperature for 10-75 minutes.
- ED AC soluble carbodiimide
- succinimidyl esters and isothiocyanates as well as other crosslinking agents may be used for covalent coupling of proteins and lectins to the microspheres.
- the mixture is centrifuged and the pellets containing the antigen or antibody linked to the fluorescent microparticles are suspended in a buffer containing 1-5% bovine serum albumin for one hour. After one more centrifugation, the spheres are resuspended in buffer (TBS with 5% BSA or other appropriate buffers) and stored at 4 degrees C before use.
- the solid phase particles useful in connection with the invention may comprise, for example, particles of latex or of other support materials such as silica, agarose, glass, polyacrylamides, polymethyl methacrylates, carboxylate modified latex and Sepharose.
- the particles will vary in size from about 0.2 microns to about 10 microns.
- useful commercially available materials include .99 micron carboxylate modified latex, cyanogen bromide activated Sepharose beads (Sigma), fused silica particles (Ciba Corning, lot #6), isothiocyanate glass (Sigma), Reactogel 25DF (Pierce) and Polybead - carboxylate monodisperse microspheres.
- such particles may be coated with a layer of antigens coupled thereto in a manner known per se in the art to present the solid phase component.
- the sample contains antibodies which will react with the gold labeled antigen, forming an antigen-antibody complex.
- the gold-antigen antibody complex begins to migrate along the test strip.
- the first binding site 18 is preferably to bind IgM.
- the second binding site 19 is preferably a site to bind IgA.
- the third binding site 20 is for the binding of IgG and the fourth binding site 22 is for a control. More specifically, each binding site is in the form of a striped line along the width of the test strip opening 9.
- anti-Ig immunoglobulins For example, class specific antibodies are laid down on the test strip. For example, a goat anti-human IgM antibody is laid down at the first binding site 18, goat anti-human IgA antibody is laid down at the second site 19 and goat anti-human IgG antibody is laid down at the third binding site 20.
- a protein or substance containing sulfur residues that readily react with any colloidal gold compound can also be an antibody reactive with the proteins coated on the gold or microparticles surface. Since the gold or microparticles conjugate is always in excess of sample reactive antibodies, sufficient conjugate is available to react with the control line.
- the antibodies reactive with IgM, IgA and IgG can be from affinity purification of immune sera from goats, rabbits, donkeys, sheep, chickens or other animals. It may also be monoclonal antibodies directed against IgM, IgA and IgG. The antibodies used are specific for the heavy chain portion of the IgM, IgA and IgG antibodies.
- Substances reactive with IgG may be substituted for the antibody to IgG or combined with said antibody.
- the sample migrates to the site of the gold sol labeled analytes pad 16. Analytes specific for the gold sol conjugate will attach and bind, thus forming gold sol labeled complexes.
- the gold sol complex continues to migrate along the length of the lateral flow strip. Reactive complexes are specifically captured by analyte (NB) coated on the test strip 7. Migration continues and complexes are captured on the control line of the test strip 7. Excess fluid is wicked into the absorbent pad 17.
- NB analyte
- the problem of separating reactivities of antibody classes lies in the 10 to 15 fold excess of IgG over IgA and IgM specific antibody reactivity with analyte reaction sites. If the IgG is allowed to react at the same time or rate as other classes of antibody, the IgG will mask most if not all the analyte epitopes, thereby decreasing or eliminating the activity of the IgM and IgA class antibodies to the analyte.
- an IgG reacting substance which can be, among others, protein A, protein G, an antibody to IgG, lentil lectin, jacalin, concanavilin A, mannan binding protein, wheat germ lectin, peanut lectin and avidchrom
- IgG reacting substance which can be, among others, protein A, protein G, an antibody to IgG, lentil lectin, jacalin, concanavilin A, mannan binding protein, wheat germ lectin, peanut lectin and avidchrom
- This large complex travels sufficiently slower than IgA, IgM, and IgE, thereby allowing these antibodies to react prior to the IgG.
- the various reacted complexes are captured specifically at three sites by the antibodies to IgM, IgA,, and IgG, or a substance reactive with IgG (protein A, protein G, lentil lectin, jacalin, concanavilin A, mannan binding protein, wheat germ lectin, peanut lectin and avidchrom).
- a serum sample is tested to determine whether it contains antibodies to H.pylori. Assuming the use of gold labels, if lines appear at the binding sites for IgG and weakly for IgM, then there is only a chronic condition present. If however, lines appear at the binding sites for IgM and IgA, with or without IgG, then an active or recent colonizing infection is occurring. The detection of IgA when combined with a low serum pepsinogen level is associated with an increased risk of gastric cancer.
- This test can detect the presence of class specific antibodies reactive with any bacteria, virus, fungus, irritant, or protein.
- Some, but not all of the analytes which can be detected using this method include Streptococcus Group A, Streptococcus Group B, Mycobacterium, Mycobacterium tuberculosis, Mycoplasma, Chlamydiae, Rickettsiae, Herpes virus, CMN, Hepatitis A, Hepatitis C, Hepatitis B, Influenza, HIV I, HIV H, HTLV I & H, Chagus, Toxoplasma, Helminh, ⁇ ematodes, autoimmune antigens, antibodies to heat shock proteins, transplantation analytes, histocompatability analytes, and combinations thereof.
- this lateral flow assay can be used for the visual detection of allergen specific IgE antibodies in human or animal serum.
- the test serum reacts with a colorimetric (preferably gold) labeled anti-IgE antibody contained in the colorimetric (preferably dried) gold pad. 16.
- the resulting complex travels along the test strip to the line stripped allergen site 24.
- the immunoassay can easily test for one or more different allergens, preferably by one strip 25, two strips (25 and 26) or multiple strips next to each other. Each strip can contain one or more specific allergen lines.
- the common allergens which may be tested include but are not limited to pollens (Timothy, cultivated rye, birch, alder, hazelnut, mugwort, English plantain, ragweed, nettle, etc.), dust allergens (D. farinae, D.
- allergens are immobilized on the test strip by the use of solubilizing agents such as sugars and alcohols (sucrose, mannose, fructose, ethylene glycol, ethanol, methanol, glycerin, dextrans).
- the assay validity is demonstrated by the appearance of a red colored line in the positive control region of the membrane.
- the positive control is a protein or substance containing sulfur residues that readily react with any colloidal gold compound. It can also be an antibody reactive with the proteins coated on the gold or microparticles surface. Since the gold or microparticles conjugate is in excess, sufficient conjugate is available to react with the control line.
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/689,682 | 2000-10-13 | ||
US09/689,682 US6528325B1 (en) | 2000-10-13 | 2000-10-13 | Method for the visual detection of specific antibodies in human serum by the use of lateral flow assays |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002056017A1 true WO2002056017A1 (en) | 2002-07-18 |
Family
ID=24769492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/042668 WO2002056017A1 (en) | 2000-10-13 | 2001-10-12 | Lateral flow assay for detection of antibodies in human serum |
Country Status (2)
Country | Link |
---|---|
US (2) | US6528325B1 (en) |
WO (1) | WO2002056017A1 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007063423A1 (en) | 2005-05-23 | 2007-06-07 | Phadia Ab | Two step lateral flow assay methods and devices |
EP2282206A2 (en) | 2004-02-17 | 2011-02-09 | DST Diagnostische Systeme & Technologien GmbH | Method and apparatus for assaying several analytes simultaneously with an internal control |
CN101363856B (en) * | 2008-05-26 | 2012-07-04 | 北京庄笛浩禾生物医学科技有限公司 | Test paper strip for rapidly detecting morbilli and rubella virus IgG antibody colloidal gold |
CN103995106A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific spices allergens IgE (Immunoglobulin E) and preparation method thereof |
CN103995116A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific cephalosporin antibiotic allergen IgE (Immunoglobulin E) and preparation method thereof |
CN103995113A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific tetanus antitoxin allergen IgE (Immunoglobulin E) and preparation method thereof |
CN103995135A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific mushroom allergen IgE and preparation method thereof |
CN103995134A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific cottons allergens IgE (Immunoglobulin E) and preparation method thereof |
CN103995118A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening meat allergen IgE (Immunoglobulin E) and preparation method thereof |
CN103995105A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific insulin allergens IgE (Immunoglobulin E) and preparation method thereof |
CN104101703A (en) * | 2013-04-11 | 2014-10-15 | 南昌大学 | Apparatus for rapidly detecting cow's milk allergens in food, and making method thereof |
CN104101581A (en) * | 2013-04-11 | 2014-10-15 | 南昌大学 | Apparatus for rapidly detecting allergic peanut proteins in food, and making method thereof |
WO2017132578A1 (en) * | 2016-01-29 | 2017-08-03 | Advanced Animal Diagnostics, Inc. | Methods and compositions for detecting mycoplasma exposure |
WO2019216775A1 (en) * | 2018-05-10 | 2019-11-14 | Koru Diagnostics Limited | Device for detection of antibodies to a pathogen |
EP3936866A1 (en) * | 2020-07-10 | 2022-01-12 | Spectral Med Solution AG | Method of rapid detection and monitoring of anti sars-cov-2 antibodies |
Families Citing this family (129)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10006432A1 (en) * | 2000-02-14 | 2001-08-16 | Ganzimmun Inst Fuer Ganzheitli | Method for the detection of Helicobacter pylori in stool and saliva samples |
EP1195606A1 (en) * | 2000-10-03 | 2002-04-10 | VBC-Genomics Forschungsges.m.b.H. | Allergen-microarray assay |
US8110218B2 (en) * | 2000-11-30 | 2012-02-07 | The Research Foundation Of State University Of New York | Compositions and methods for less immunogenic protein-lipid complexes |
US7625584B2 (en) * | 2000-11-30 | 2009-12-01 | The Research Foundation Of State University Of New York | Method of complexing a protein by the use of a dispersed system and proteins thereof |
US7197531B2 (en) * | 2000-12-29 | 2007-03-27 | Fotomedia Technologies, Llc | Meta-application architecture for integrating photo-service websites for browser-enabled devices |
CA2429372A1 (en) * | 2001-01-03 | 2002-08-29 | Heska Corporation | Detection of allergen-specific ige |
US20020192676A1 (en) * | 2001-06-18 | 2002-12-19 | Madonna Angelo J. | Method for determining if a type of bacteria is present in a mixture |
US7291477B2 (en) | 2001-07-03 | 2007-11-06 | Xenotope Diagnostics, Inc. | Method and device for trichomonas detection |
US20030044869A1 (en) * | 2001-09-04 | 2003-03-06 | Yeung Jupiter M. | Method and apparatus for detecting protein in a sample |
SE0103072D0 (en) * | 2001-09-17 | 2001-09-17 | Pharmacia Diagnostics Ab | Multi-analyte assay device with multi-spot detection zone |
US20030109067A1 (en) * | 2001-12-06 | 2003-06-12 | Immunetech, Inc. | Homogeneous immunoassays for multiple allergens |
US20030198573A1 (en) * | 2002-01-25 | 2003-10-23 | Illumina, Inc. | Sensor arrays for detecting analytes in fluids |
US7491491B2 (en) * | 2002-03-12 | 2009-02-17 | Polytechnic Institute Of New York University | Detecting and/or measuring a substance based on a resonance shift of photons orbiting within a microsphere |
US20050003346A1 (en) * | 2002-04-12 | 2005-01-06 | Colorado School Of Mines | Apparatus and method for detecting microscopic living organisms using bacteriophage |
US8216780B2 (en) * | 2002-04-12 | 2012-07-10 | Microphage (Tm) Incorporated | Method for enhanced sensitivity in bacteriophage-based diagnostic assays |
AU2003228505B2 (en) * | 2002-04-12 | 2009-01-08 | Colorado School Of Mines | Method for detecting low concentrations of a target bacterium that uses phages to infect target bacterial cells |
US20030203412A1 (en) * | 2002-04-26 | 2003-10-30 | Aristo Vojdani | Immunoassay for detection of antibodies for molds and mycotoxins |
AU2003240145A1 (en) * | 2002-06-27 | 2004-01-19 | Unipath Limited | Assay reader |
US6927062B2 (en) * | 2002-11-25 | 2005-08-09 | Agdia, Inc. | Controls and standards for assays and method for manufacture thereof |
TWI340829B (en) * | 2002-12-27 | 2011-04-21 | Transpacific Systems Llc | Method for determining a response of each probe zone on a test strip |
US7197169B2 (en) * | 2003-01-02 | 2007-03-27 | Kuo-Jeng Wang | Method for detecting a response of each probe zone on a test strip |
GB0301225D0 (en) * | 2003-01-20 | 2003-02-19 | Univ Sunderland | Surface layer immuno-chromatography |
ATE448866T1 (en) * | 2003-02-19 | 2009-12-15 | Natrix Separations Inc | SUPPORTED POROUS GELS COMPRISING COMPOSITE MATERIALS |
CN101375163B (en) * | 2003-04-10 | 2012-03-21 | 科罗拉多矿业学院 | Apparatus and method for detecting microscopic living organisms using bacteriophage |
EP1613965A2 (en) * | 2003-04-10 | 2006-01-11 | Kent J. Voorhees | Apparatus and method for detecting microscopic living organisms using bacteriophage |
FR2854695B1 (en) * | 2003-05-07 | 2006-01-21 | Biomerieux Sa | REACTION MODULE FOR BIOLOGICAL ANALYSIS |
US7393697B2 (en) * | 2003-06-06 | 2008-07-01 | Advantage Diagnostics Corporation | Diagnostic test for analytes in a sample |
US7378285B2 (en) | 2003-09-22 | 2008-05-27 | Paul Lambotte | Devices for the detection of multiple analytes in a sample |
US8182694B2 (en) * | 2004-04-08 | 2012-05-22 | Natrix Separations Inc. | Membrane stacks |
EP1773485B1 (en) * | 2004-06-07 | 2015-09-16 | Natrix Separations Inc. | Stable composite material comprising supported porous gels |
US20060008920A1 (en) * | 2004-07-09 | 2006-01-12 | Branan Medical Corporation | Combination assay for alcohol and drugs of abuse |
EP1786460A4 (en) * | 2004-08-26 | 2008-04-02 | Sequella Inc | Assay for detecting tuberculosis in nonhuman primates |
US7629127B2 (en) * | 2005-01-21 | 2009-12-08 | Dexall Biomedical Labs, Inc. | Method for the visual detection of specific antibodies by the use of lateral flow assays |
US7189522B2 (en) | 2005-03-11 | 2007-03-13 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
WO2006098804A2 (en) * | 2005-03-11 | 2006-09-21 | Chembio Diagnostic Systems, Inc. | Dual path immunoassay device |
US20110097702A1 (en) * | 2005-03-31 | 2011-04-28 | Voorhees Kent J | Methods and compositions for in situ detection of microorganisms on a surface |
WO2006105504A1 (en) * | 2005-03-31 | 2006-10-05 | Microphage Incorporated | Apparatus and method for detecting microorganisms using flagged bacteriophage |
US20060246522A1 (en) * | 2005-04-28 | 2006-11-02 | Bhullar Balwant S | C-reactive protein immunoassay and method |
EP1882184A4 (en) * | 2005-05-20 | 2008-07-30 | Calypte Biomedical Corp | Oral fluid rapid immunochromatography test |
KR101068612B1 (en) * | 2005-05-24 | 2011-09-30 | 휴마시스 주식회사 | Diagnostic device for measuring the ratio of similar structual protein |
US7595152B2 (en) * | 2005-07-01 | 2009-09-29 | Arbor Vita Corporation | Detection of influenza virus |
US8017103B2 (en) * | 2005-07-01 | 2011-09-13 | Board Of Regents, The University Of Texas System | Methods and compositions to diagnose trichomonas infection |
US20070015224A1 (en) * | 2005-07-01 | 2007-01-18 | Board Of Regents, The University Of Texas System | Methods and compositions to diagnose Trichomonas infection |
US20070059678A1 (en) * | 2005-08-29 | 2007-03-15 | King Shannon L | Breast milk contaminant detection device |
US7439028B2 (en) * | 2005-09-30 | 2008-10-21 | Board Of Regents, The University Of Texas System | Methods and compositions to correlate Trichomonas infection with prostate cancer |
US7803567B2 (en) * | 2005-12-09 | 2010-09-28 | Board Of Regents, The University Of Texas System | Methods and compositions for detecting trichomonas in a sample contacted with fixative |
US20090053694A1 (en) * | 2005-12-26 | 2009-02-26 | Kriksunov Leo B | Photochemically Amplified Bioassay |
ES2558309T3 (en) * | 2006-07-25 | 2016-02-03 | Augurix S.A. | Immunochromatography device for the diagnosis of diseases in a sample |
US7749775B2 (en) | 2006-10-03 | 2010-07-06 | Jonathan Scott Maher | Immunoassay test device and method of use |
US8003312B2 (en) * | 2007-02-16 | 2011-08-23 | The Board Of Trustees Of The Leland Stanford Junior University | Multiplex cellular assays using detectable cell barcodes |
WO2008105764A2 (en) * | 2007-02-28 | 2008-09-04 | King Shannon L | Breast milk contaminant detection device |
JP4360652B2 (en) * | 2007-06-08 | 2009-11-11 | 古河電気工業株式会社 | Labeled silica nanoparticles for immunochromatography reagent, immunochromatography reagent, test strip for immunochromatography using the same, and fluorescence detection system for immunochromatography |
AU2008265989B8 (en) * | 2007-06-15 | 2012-01-12 | Microphage Incorporated | Method of detection of microorganisms with enhanced bacteriophage amplification |
US8053203B2 (en) * | 2007-10-30 | 2011-11-08 | John Wan | Methods and device for the detection of occult blood |
US8697434B2 (en) * | 2008-01-11 | 2014-04-15 | Colorado School Of Mines | Detection of phage amplification by SERS nanoparticles |
US8247220B2 (en) * | 2008-02-01 | 2012-08-21 | Kimberly-Clark Worldwide, Inc. | Optical indicator for detecting bacterial pathogens |
US8157747B2 (en) * | 2008-02-15 | 2012-04-17 | Lary Research & Development, Llc | Single-use indicator for a surgical instrument and a surgical instrument incorporating same |
WO2009111254A2 (en) * | 2008-02-29 | 2009-09-11 | Biomedomics, Inc. | A rapid and sensitive method for quantitative determination of the level of heparin-pf4 complex induced immunoglobulin antibodies |
US9441204B2 (en) * | 2008-04-03 | 2016-09-13 | Colorado School Of Mines | Compositions and methods for detecting Yersinia pestis bacteria |
WO2009143081A2 (en) * | 2008-05-19 | 2009-11-26 | Idexx Laboratories, Inc. | Methods, devices kits and compositions for detecting roundworm |
WO2009143080A2 (en) | 2008-05-19 | 2009-11-26 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
KR101420478B1 (en) | 2008-05-19 | 2014-07-28 | 아이덱스 래보러토리즈, 인코포레이티드 | Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm |
WO2009149293A1 (en) * | 2008-06-04 | 2009-12-10 | Ds Genomics | Rapid detection of post-vaccination antibody response |
JP2010032505A (en) * | 2008-06-30 | 2010-02-12 | Arkray Inc | Detection method of target substance, detection reagent used for the same, and uses thereof |
US20100022916A1 (en) | 2008-07-24 | 2010-01-28 | Javanbakhsh Esfandiari | Method and Apparatus for Collecting and Preparing Biological Samples for Testing |
KR101694426B1 (en) | 2008-09-02 | 2017-01-09 | 나트릭스 세퍼레이션즈, 인코포레이티드 | Chromatography membranes, devices containing them, and methods of use thereof |
GB0905519D0 (en) | 2009-03-31 | 2009-05-13 | Biofortuna Ltd | Assay method and device |
CN101900729B (en) * | 2009-05-29 | 2014-10-29 | 杨圣佐 | Test paper for detecting streptococcus suis, and preparation method and application thereof |
US20100317033A1 (en) * | 2009-06-10 | 2010-12-16 | Matthew Philip Abdel | Methods and materials for detecting food containing allergens |
WO2011032278A1 (en) * | 2009-09-17 | 2011-03-24 | Neoventures Biotechnology Limited | A method and apparatus for lateral flow determination of analyte concentration |
CA2780807C (en) * | 2009-11-17 | 2020-01-21 | Idexx Laboratories, Inc. | Methods, devices, kits and compositions for detecting roundworm |
US10585098B2 (en) | 2009-11-23 | 2020-03-10 | The Johns Hopkins University | Optimizing diagnostics for galactofuranose containing antigens |
US10288611B2 (en) | 2009-11-23 | 2019-05-14 | The Johns Hopkins University | Lateral flow device for diagnosing microbial infections |
US8198035B2 (en) | 2009-11-25 | 2012-06-12 | Siemens Healthcare Diagnostics Inc. | Galactose-α-1,3-galactose-macromolecule conjugates and methods employing same |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
CN101788562A (en) * | 2010-03-26 | 2010-07-28 | 天津中新科炬生物制药有限公司 | Influenza A (H1N1) virus total antibody rapid detection test paper |
CN101788561A (en) * | 2010-03-26 | 2010-07-28 | 天津中新科炬生物制药有限公司 | Influenza A (H1N1) virus IgM and total antibody rapid detection test paper |
US8956859B1 (en) | 2010-08-13 | 2015-02-17 | Aviex Technologies Llc | Compositions and methods for determining successful immunization by one or more vaccines |
US8603835B2 (en) | 2011-02-10 | 2013-12-10 | Chembio Diagnostic Systems, Inc. | Reduced step dual path immunoassay device and method |
WO2012151465A1 (en) * | 2011-05-04 | 2012-11-08 | Pop Test, Llc | Diagnostic device |
ES2686340T3 (en) | 2011-05-17 | 2018-10-17 | Natrix Separations Inc. | Method of using rolled membranes for chromatography |
CA2832109C (en) | 2011-06-10 | 2021-07-06 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
US9274105B2 (en) * | 2011-07-13 | 2016-03-01 | Optrotrace (SuZhou) Technologies, Inc. | Analyzing chemical and biological substances using nano-structure based spectral sensing |
CN102288758A (en) * | 2011-07-29 | 2011-12-21 | 北京中检安泰诊断科技有限公司 | Hepatitis A virus (HAV) IgM antibody colloidal gold method detection kit and preparation method thereof |
US20140356884A1 (en) * | 2011-08-23 | 2014-12-04 | Sukant Mittal | Boundary Layer Suction for Cell Capture |
EP2568289A3 (en) | 2011-09-12 | 2013-04-03 | International AIDS Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
CN102507932A (en) * | 2011-12-02 | 2012-06-20 | 无锡博慧斯生物医药科技有限公司 | IgM (immunoglobulin M) antibody detection test strip |
ES2407055B1 (en) * | 2011-12-07 | 2014-04-16 | Universidad Pablo De Olavide | EMPLOYMENT OF ANTI-BETA-LACTOGLOBULIN ANTIBODIES IN THE DIAGNOSIS AND FOLLOW-UP OF CELIAC DISEASE |
JP5931449B2 (en) * | 2012-01-11 | 2016-06-08 | 日東電工株式会社 | Pharmaceutical composition and method for producing the same |
JP6248030B2 (en) * | 2012-04-06 | 2017-12-13 | コニカミノルタ株式会社 | Analyte detection or quantification method, analyte detection or quantification kit, and lateral flow chromatographic test strip for analyte detection or quantification |
ES2631608T3 (en) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Env-glycoprotein variant of HIV-1 |
JP6273107B2 (en) * | 2013-08-02 | 2018-01-31 | デンカ生研株式会社 | Method for enhancing detection light using light reflector in immunochromatography |
US9470684B2 (en) * | 2013-08-06 | 2016-10-18 | Techlab, Inc. | Outer membrane protein 18 as a diagnostic marker for campylobacter |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
WO2015095195A1 (en) | 2013-12-16 | 2015-06-25 | The Johns Hopkins University | Interferon-gamma release assays for diagnosis of invasive fungal infections |
GB2548653A (en) | 2014-04-02 | 2017-09-27 | Chembio Diagnostic Systems Inc | Immunoassay utilizing trapping conjugate |
CN103983789B (en) * | 2014-05-28 | 2016-03-02 | 中生北控生物科技股份有限公司 | For the test strips and preparation method thereof of specificity dirt mite class anaphylactogen IgE examination |
CN103983792B (en) * | 2014-05-29 | 2015-09-30 | 同昕生物技术(北京)有限公司 | A kind of immunoglobulin (Ig) lateral chromatography detection system |
CN104764882A (en) * | 2014-08-20 | 2015-07-08 | 苏州和锐医药科技有限公司 | Preparation method and application of anti-BPI-ANCA antibody test strip |
US20160116466A1 (en) | 2014-10-27 | 2016-04-28 | Chembio Diagnostic Systems, Inc. | Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses |
US9981264B2 (en) | 2014-11-04 | 2018-05-29 | Grace Bio-Labs, Inc. | Nitrocellulose extrusion for porous film strips |
US10174292B2 (en) | 2015-03-20 | 2019-01-08 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US9931394B2 (en) | 2015-03-23 | 2018-04-03 | International Aids Vaccine Initiative | Soluble HIV-1 envelope glycoprotein trimers |
US20160305954A1 (en) * | 2015-04-17 | 2016-10-20 | Kenneth Davin Fine | Diagnostic testing for immunologic food sensitivity |
USD771834S1 (en) * | 2015-04-28 | 2016-11-15 | University Of British Columbia | Microfluidic cartridge |
CN105424923B (en) * | 2015-09-10 | 2018-01-05 | 南京微测生物科技有限公司 | Difunctional immuno-chromatographic test paper strip of color fluorescence and preparation method thereof |
US20170089893A1 (en) * | 2015-09-24 | 2017-03-30 | Globallergy, Llc | Chromatographic immune assay for the detection of allergic sensitivities |
EP3153230A1 (en) * | 2015-10-08 | 2017-04-12 | The Provost, Fellows, Foundation Scholars, & the other members of Board, of the College of Holy and Undiv. Trinity of Queen Elizabeth near Dublin | A method for the production of poly(methyl methacrylate) (pmma) membranes and uses thereof |
CN105353133A (en) * | 2015-11-17 | 2016-02-24 | 苏州浩欧博生物医药有限公司 | Kit detecting dermatophagoides-farinae allergen specific IgE antibody and method |
CN105403692A (en) * | 2015-11-17 | 2016-03-16 | 苏州浩欧博生物医药有限公司 | Kit and method for detecting dermatophagoides pteronyssinus allergen specificity IgE antibody |
CN105353134A (en) * | 2015-11-17 | 2016-02-24 | 苏州浩欧博生物医药有限公司 | Kit detecting dog-hair allergen specific IgE antibody and method |
US20170160275A1 (en) * | 2015-12-03 | 2017-06-08 | Firdausi Qadri | Blood-based lateral-flow dipstick assay for detection of enteric fever |
CN106066399A (en) * | 2016-05-24 | 2016-11-02 | 深圳市前海安测信息技术有限公司 | The preparation method of the colloidal gold strip of detection early diabetic nephropathy |
KR20180049602A (en) * | 2016-11-03 | 2018-05-11 | (의료)길의료재단 | Method to diagnose allergy by determination of Immunoglobulin E using an immunoassay based on based on enzyme-mimicking nanozymes |
CN107247149A (en) * | 2017-05-23 | 2017-10-13 | 哈尔滨医科大学 | A kind of dermatophagoides pteronyssinus specific IgE half-quantitative detection kit and application thereof |
CN107290547A (en) * | 2017-08-07 | 2017-10-24 | 广州市微米生物科技有限公司 | A kind of infertile quick detection kit and preparation method thereof |
CN109541215A (en) * | 2018-12-20 | 2019-03-29 | 中国人民解放军陆军军医大学 | A kind of lesion detection object and the preparation method and application thereof |
WO2020166698A1 (en) * | 2019-02-14 | 2020-08-20 | 東洋紡株式会社 | Immunochromatographic test piece, and measurement method using same |
JPWO2020166699A1 (en) * | 2019-02-15 | 2021-12-16 | 東洋紡株式会社 | Lateral flow test piece and measurement method using it |
SE1950251A1 (en) * | 2019-02-27 | 2020-08-28 | Alpha Biotech Ab | Rickettsia assay |
RU2726484C1 (en) * | 2019-04-29 | 2020-07-14 | федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации | Diagnostic technique for rickettsial diseases group of spotted fever, immunoassay diagnostic test system for implementation thereof |
CN110646616B (en) * | 2019-09-05 | 2023-05-30 | 桂林理工大学 | Super-sensitive fluorescence quenching immunosensor for detecting human cTnI in serum and detection method |
WO2021086544A1 (en) * | 2019-10-27 | 2021-05-06 | Ke Zhang | A reverse lfia for ige |
CN111965349A (en) * | 2019-11-28 | 2020-11-20 | 上海荣盛生物药业有限公司 | Composition for fluorescence immunochromatography detection and application of composition in HIV detection |
WO2021252810A1 (en) | 2020-06-10 | 2021-12-16 | Checkable Medical Incorporated | In vitro diagnostic device |
CN112067811B (en) * | 2020-08-17 | 2023-08-11 | 北京勤邦科技股份有限公司 | Test strip for detecting alternaria alternate and application thereof |
JPWO2022050264A1 (en) * | 2020-09-01 | 2022-03-10 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2204398A (en) * | 1987-04-27 | 1988-11-09 | Unilever Plc | Assays |
US5486452A (en) * | 1981-04-29 | 1996-01-23 | Ciba-Geigy Corporation | Devices and kits for immunological analysis |
US5494830A (en) * | 1987-10-21 | 1996-02-27 | Hubscher; Thomas T. | Methods for performing determinations of immune reactants in biological fluids |
US5807752A (en) * | 1992-09-11 | 1998-09-15 | Boehringer Mannheim Corporation | Assay using an unblocked solid phase with immobilized analyte binding partner |
US6100099A (en) * | 1994-09-06 | 2000-08-08 | Abbott Laboratories | Test strip having a diagonal array of capture spots |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3842700A1 (en) * | 1988-12-19 | 1990-06-21 | Boehringer Mannheim Gmbh | METHOD FOR PROTEIN IMMOBILIZATION ON A SOLID PHASE, PROTEIN-CARRYING SOLID PHASE PRODUCED THEREOF AND THE USE THEREOF |
US4968604A (en) * | 1989-07-20 | 1990-11-06 | Neorx Corporation | Method and test kit for detection of antibodies |
-
2000
- 2000-10-13 US US09/689,682 patent/US6528325B1/en not_active Expired - Lifetime
-
2001
- 2001-10-12 WO PCT/US2001/042668 patent/WO2002056017A1/en active Application Filing
- 2001-10-12 US US09/974,913 patent/US6824975B2/en not_active Expired - Lifetime
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486452A (en) * | 1981-04-29 | 1996-01-23 | Ciba-Geigy Corporation | Devices and kits for immunological analysis |
GB2204398A (en) * | 1987-04-27 | 1988-11-09 | Unilever Plc | Assays |
US5494830A (en) * | 1987-10-21 | 1996-02-27 | Hubscher; Thomas T. | Methods for performing determinations of immune reactants in biological fluids |
US5807752A (en) * | 1992-09-11 | 1998-09-15 | Boehringer Mannheim Corporation | Assay using an unblocked solid phase with immobilized analyte binding partner |
US6100099A (en) * | 1994-09-06 | 2000-08-08 | Abbott Laboratories | Test strip having a diagonal array of capture spots |
Cited By (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2282206A2 (en) | 2004-02-17 | 2011-02-09 | DST Diagnostische Systeme & Technologien GmbH | Method and apparatus for assaying several analytes simultaneously with an internal control |
US7871781B2 (en) | 2005-05-23 | 2011-01-18 | Phadia Ab | Two step lateral flow assay methods and devices |
EP1891447B1 (en) * | 2005-05-23 | 2011-07-06 | Phadia AB | Two step lateral flow assay methods and devices |
AU2006321289B2 (en) * | 2005-05-23 | 2011-12-08 | Phadia Ab | Two step lateral flow assay methods and devices |
CN101184999B (en) * | 2005-05-23 | 2013-03-27 | 法迪亚股份有限公司 | Two step lateral flow assay methods and devices |
WO2007063423A1 (en) | 2005-05-23 | 2007-06-07 | Phadia Ab | Two step lateral flow assay methods and devices |
US9034657B2 (en) | 2005-05-23 | 2015-05-19 | Phadia Ab | Two step lateral flow assay methods and devices |
CN101363856B (en) * | 2008-05-26 | 2012-07-04 | 北京庄笛浩禾生物医学科技有限公司 | Test paper strip for rapidly detecting morbilli and rubella virus IgG antibody colloidal gold |
CN104101703A (en) * | 2013-04-11 | 2014-10-15 | 南昌大学 | Apparatus for rapidly detecting cow's milk allergens in food, and making method thereof |
CN104101581A (en) * | 2013-04-11 | 2014-10-15 | 南昌大学 | Apparatus for rapidly detecting allergic peanut proteins in food, and making method thereof |
CN103995106A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific spices allergens IgE (Immunoglobulin E) and preparation method thereof |
CN103995118B (en) * | 2014-05-28 | 2016-01-13 | 中生北控生物科技股份有限公司 | For the test strips and preparation method thereof of meat anaphylactogen IgE examination |
CN103995118A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening meat allergen IgE (Immunoglobulin E) and preparation method thereof |
CN103995105A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific insulin allergens IgE (Immunoglobulin E) and preparation method thereof |
CN103995135A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific mushroom allergen IgE and preparation method thereof |
CN103995113A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific tetanus antitoxin allergen IgE (Immunoglobulin E) and preparation method thereof |
CN103995116A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific cephalosporin antibiotic allergen IgE (Immunoglobulin E) and preparation method thereof |
CN103995105B (en) * | 2014-05-28 | 2016-01-13 | 中生北控生物科技股份有限公司 | For the test strips and preparation method thereof of specificity detecting insulin allergen IgE examination |
CN103995116B (en) * | 2014-05-28 | 2016-01-13 | 中生北控生物科技股份有限公司 | For the test strips and preparation method thereof of specificity cephalosporins anaphylactogen IgE examination |
CN103995134A (en) * | 2014-05-28 | 2014-08-20 | 中生北控生物科技股份有限公司 | Test strip for screening specific cottons allergens IgE (Immunoglobulin E) and preparation method thereof |
CN103995106B (en) * | 2014-05-28 | 2016-01-13 | 中生北控生物科技股份有限公司 | For the test strips and preparation method thereof of specificity perfumery anaphylactogen IgE examination |
CN103995135B (en) * | 2014-05-28 | 2016-01-13 | 中生北控生物科技股份有限公司 | For the test strips and preparation method thereof of specificity mushroom class anaphylactogen IgE examination |
CN103995134B (en) * | 2014-05-28 | 2016-02-03 | 中生北控生物科技股份有限公司 | For the test strips and preparation method thereof of specificity cotton class anaphylactogen IgE examination |
CN103995113B (en) * | 2014-05-28 | 2016-03-02 | 中生北控生物科技股份有限公司 | For the test strips and preparation method thereof of specificity tetanus antitoxin anaphylactogen IgE examination |
WO2017132578A1 (en) * | 2016-01-29 | 2017-08-03 | Advanced Animal Diagnostics, Inc. | Methods and compositions for detecting mycoplasma exposure |
US10222383B2 (en) | 2016-01-29 | 2019-03-05 | Advanced Animal Diagnostics, Inc. | Methods and compositions for detecting mycoplasma exposure |
WO2019216775A1 (en) * | 2018-05-10 | 2019-11-14 | Koru Diagnostics Limited | Device for detection of antibodies to a pathogen |
EP3936866A1 (en) * | 2020-07-10 | 2022-01-12 | Spectral Med Solution AG | Method of rapid detection and monitoring of anti sars-cov-2 antibodies |
Also Published As
Publication number | Publication date |
---|---|
US6824975B2 (en) | 2004-11-30 |
US6528325B1 (en) | 2003-03-04 |
US20020045195A1 (en) | 2002-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6824975B2 (en) | Incorporation of selective binding substances in a solid phase assay device | |
US7629127B2 (en) | Method for the visual detection of specific antibodies by the use of lateral flow assays | |
AU621038B2 (en) | Assay techniques | |
AU614294B2 (en) | Process for immunochromatography with colloidal particles | |
US8349620B2 (en) | Highly sensitive immunoassay systems for detecting multiple allergens | |
EP0636886B1 (en) | A calibrator or control composition for an IgM serology assay | |
EP0813064B1 (en) | Method for amplification of the response signal in a sandwich immunoassay | |
CN1879019B (en) | Circulation test device and method for assaying presence or quantity of analyte of assay sample | |
US7491551B2 (en) | Quantitative lateral flow assays and devices | |
CA1272127A (en) | Solid phase system for use in ligand-receptor assays | |
US20080138842A1 (en) | Indirect lateral flow sandwich assay | |
PL196464B1 (en) | Neutralisation of polycations in chromatographic equipment used to analyse whole blood | |
JP2002202307A (en) | Immunochromatography | |
CA2039958A1 (en) | Binding of allergens to a solid phase | |
WO1999064864A9 (en) | Optimizing sensitivity in colloidal colorimetric flow through and lateral flow tests | |
JP3833358B2 (en) | A homogeneous detection method for the measurement of subpopulations of analytes | |
JP2002286716A (en) | Immunochromatograph ic method capable of simultaneous analysis of a plurality of items and strip for immunochromatography | |
WO1999064863A1 (en) | Colloidal colorimetric flow through and lateral flow assays utilizing soluble submicron particles | |
JP2002340897A (en) | Immuno-chromatograph method enabling simultaneous analysis of plural items and total content and strip for immuno-chromatograph | |
JPH1068730A (en) | Test tool for immunochromatography | |
CA1335321C (en) | Process for immunochromatography with colloidal particles | |
JPH0382962A (en) | Method of detecting antibody to hepatitis b virus core antigen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |